Skip to content
Recovery & Performance PeptidesRecovery research and practical context
  • MS Akman et al.

    Mechanisms of action of a second generation growth hormone-releasing peptide (Ala-His-dd

    Endocrinology

    (1993)

  • JA Aloi et al.

    Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects

    J Clin Endocrinol Metab

    (1994)

  • DK Alster et al.

    The growth hormone (GH) response to GH-releasing peptide (His-dd

    J Clin Endocrinol Metab

    (1993)

  • M Arosio et al.

    Effects of Hexarelin (EP23905-MF6003) on circulating GH levels in acromegalic patients. (Highlights inMol Clin Endocrinol

    Front Endocrinol

    (1994)

  • E Arvat et al.

    Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects

    J Clin Endocrinol Metab

    (1994)

  • E Arvat et al.

    Modulation of growth hormone-releasing activity of hexarelin in man

    Neuroendocrinology

    (1995)

  • E Arvat et al.

    Supramaximal doses of GHRH or Hexarelin, a synthetic hexapeptide, enhance the low somatotrope responsiveness in aging

    J Endocrinol Invest

    (1996)

  • E Arvat et al.

    Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man

    J Endocrinol Invest

    (1996)

  • E Arvat et al.

    Oestrogen replacement does not restore the reduced GH-releasing activity of hexarelin, a synthetic hexapeptide, in postmenopausal women

    Eur J Endocrinol

    (1997)

  • E Arvat et al.

    Effects of histaminergic antagonists on the GH-releasing activity of GHRH or hexarelin, a synthetic hexapeptide, in man

    J Endocrinol Invest

    (1997)

  • TM Badger et al.

    The effects of growth hormone (GH)-releasing peptides on GH secretion in perifused pituitary cells of adult male rats

    Endocrinology

    (1984)

  • AD Blake et al.

    Desensitization studies using perifused rat pituitary cells show that growth hormone-releasing hormone and His-dd

    J Endocrinol

    (1991)

  • J Bellone et al.

    Growth hormone-releasing activity of Hexarelin, a new synthetic hexapeptide, before and during puberty

    J Clin Endocrinol Metab

    (1995)

  • J Bellone et al.

    Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature

    Eur J Endocrinol

    (1995)

  • BB Bercu et al.

    Sex differences in growth hormone (GH) secretion by rats administered GH-releasing hexapeptide

    Endocrinology

    (1991)

  • BB Bercu et al.

    Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: Analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin-releasing hormone

    Endocrinology

    (1992)

  • CY Bowers et al.

    On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone

    Endocrinology

    (1984)

  • CY Bowers et al.

    Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone

    J Clin Endocrinol Metab

    (1990)

  • CY Bowers et al.

    On the action of the growth hormone-releasing hexapeptide, GHRP

    Endocrinology

    (1991)

  • CY Bowers et al.

    The growth hormone-releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration

    J Clin Endocrinol Metab

    (1992)

  • CY Bowers et al.

    Atypical growth hormone releasing peptides

    Growth Hormone II, Basic and Clinical Aspects

    (1993)

  • CY Bowers

    GH releasing peptides: Structure and kinetics

    J Pediatr Endocrinol

    (1993)

  • CY Bowers

    Novel GH-releasing peptides

  • M Cappa et al.

    Exogenous growth hormone administration does not inhibit the growth hormone response to Hexarelin in normal men

    J Endocrinol Invest

    (1995)

  • CH Chang et al.

    Activity of a novel non peptidyl GH secretagogue, L-700,653, in swine

    Endocrinology

    (1995)

  • Chang, C, H, Faidley, T, Rickes, L, McGuire, L, A, Nicolich, S, Murphy, T, Frazier, E, Chen, H, Smith, R, G, Hickey, J,...
  • IM Chapman et al.

    Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects

    J Clin Endocrinol Metab

    (1996)

  • IM Chapman et al.

    Enhancement of pulsatile growth hormone secretory by continous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults—A clinical research center study

    J Clin Endocrinol Metab

    (1996)

  • Chapman, I, M, Pescovitz, O, H, Treep, T, Murphy, G, Cerchio, K, Krupa, D, Gertz, B, Polvino, W, Skiles, E, H, Pezzoli,...
  • P Chatelain et al.

    Fetal and neonatal somatotroph function

    Front Paediatr Neuroendocrinol

    (1994)

  • K Cheng et al.

    The synergistic effects of His-dd

    Endocrinology

    (1989)

  • K Cheng et al.

    A novel non-peptidyl growth hormone secretagogue

    Horm Res

    (1993)

  • K Cheng et al.

    Stimulation of growth hormone release from rat primary pituitary cells by L-692,429, a novel non-peptidyl GH secretagogue

    Endocrinology

    (1993)

  • K Chihara et al.

    Growth hormone releasing hexapeptide: Basic research and clinical application

  • E Ciccarelli et al.

    Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinemia patients

    Clin Endocrinol

    (1996)

  • RG Clark et al.

    The effects of a growth hormone-releasing peptide and growth hormone-releasing factor in conscious and anaesthetized rats

    J Neuroendocrinol

    (1989)

  • Clark, R, G, Mortenesen, D, L, Won, W, B, Ma, Y, H, Stanley, M, S, Somers, T, C, Fairhall, K, M, Thoams, G, B,...
  • LK Conley et al.

    Mechanism of action of Hexarelin and GHRP-6: Analysis of the involvement of GHRH and somatostatin in the rat

    Neuroendocrinology

    (1995)

  • G Copinschi et al.

    Effects of 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men

    J Clin Endocrinol Metab

    (1996)

  • F Cordido et al.

    Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: Evidence for a marked somatotroph secretory capability in obesity

    J Clin Endocrinol Metab

    (1993)